| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neoleukin Therapeutics, Inc. | Former Chief Medical Officer | Common Stock | 37,313 | $25,850 | $0.6928 | 03 Apr 2023 | Direct |
| Neoleukin Therapeutics, Inc. | Former Chief Medical Officer | Restricted Stock Units | 0 | 31 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NGNE | Neoleukin Therapeutics, Inc. | 31 Mar 2023 | 3 | -$2,608 | 4 | Former Chief Medical Officer | 04 Apr 2023, 20:51 |
| NGNE | Neoleukin Therapeutics, Inc. | 01 Feb 2023 | 3 | -$8,588 | 4 | Chief Medical Officer | 03 Feb 2023, 15:32 |
| NGNE | Neoleukin Therapeutics, Inc. | 02 Aug 2022 | 1 | $0 | 4 | Chief Medical Officer | 04 Aug 2022, 16:40 |
| NGNE | Neoleukin Therapeutics, Inc. | 30 Apr 2022 | 3 | -$6,749 | 4 | Chief Medical Officer | 03 May 2022, 19:16 |
| NGNE | Neoleukin Therapeutics, Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Medical Officer | 02 Feb 2022, 15:39 |
| NGNE | Neoleukin Therapeutics, Inc. | 03 Aug 2021 | 1 | $0 | 4 | Chief Medical Officer | 05 Aug 2021, 16:23 |